Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02198651
Brief Title: A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)

First Submitted : July 22, 2014
First Submitted that Met QC Criteria : July 22, 2014
First Posted : July 24, 2014 (Estimate)

Results First Submitted : April 29, 2019
Results First Submitted that Met QC Criteria : June 6, 2019
Results First Posted : June 25, 2019

Last Update Submitted that Met QC Criteria : June 6, 2019
Last Update Posted : June 25, 2019